Walgreens buys remaining 45% stake not owned in CareCentrix for ~$392M
Justin Sullivan


Walgreens Boots Alliance (NASDAQ:WBA) on Tuesday said it would buy the remaining 45% stake it does not own in post-acute and home care services provider CareCentrix for about $392M.
The full acquisition of CareCentrix follows WBA's 55% majority investment in the company for $330M, which closed in Aug. earlier this year.

The transaction in Aug. had valued CareCentrix at $800M. WBA did not provide an updated valuation on Tuesday.
CareCentrix manages care for more than 19M members through over 7.4K provider locations, offering services such as home nursing, durable medical equipment, home infusion and in-home palliative care.
"CareCentrix is key to offering services to our patients at every stage of the care continuum, and to driving long-term, sustainable growth as part of our U.S. Healthcare strategy," WBA CEO Roz Brewer said in a statement.
CareCentrix will continue as a distinct business and brand following the full acquisition, while its CEO John Driscoll will join WBA to lead U.S. Healthcare, including Walgreens Health.
Walgreens (WBA) stock +1.7% to $32.38 in early trading.